Aludex 50 g/l, Concentrate for Cutaneous Solution

Pays: Royaume-Uni

Langue: anglais

Source: VMD (Veterinary Medicines Directorate)

Ingrédients actifs:

Amitraz

Disponible depuis:

MSD Animal Health UK Limited

Code ATC:

QP53AD01

DCI (Dénomination commune internationale):

Amitraz

forme pharmaceutique:

Concentrate for cutaneous solution

Type d'ordonnance:

POM-V - Prescription Only Medicine – Veterinarian

Groupe thérapeutique:

Dogs

Domaine thérapeutique:

Ectoparasiticide

Statut de autorisation:

Expired

Date de l'autorisation:

1993-04-01

Résumé des caractéristiques du produit

Revised: June 2021
AN: 00308/2021
Page 1 of 6
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Aludex 50 g/l Concentrate for cutaneous solution
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each litre contains:
ACTIVE SUBSTANCE
Amitraz (as Amitraz technical) 50 g
For a full list of excipients see section 6.1
3.
PHARMACEUTICAL FORM
Concentrate for cutaneous solution.
Clear pale yellow liquid.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Dogs.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the control of demodectic and sarcoptic mange.
4.3
CONTRAINDICATIONS
Do not use on Chihuahuas.
Do not use on dogs suffering from heat stress.
Do not use on pregnant or lactating bitches, nor puppies less than 3
months old.
Do not use on cats.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
4.5
SPECIAL PRECAUTIONS FOR USE
i)
Special precautions for use in animals
For use on dogs only.
For external use only.
For use only under the supervision of a veterinary surgeon.
Dogs should be prevented from licking the fur after treatment.
For the treatment of demodectic mange in severely debilitated dogs use
25
ml of Aludex in 5 litres of water (half the normal dose rate)
Revised: June 2021
AN: 00308/2021
Page 2 of 6
ii)
Special precautions to be taken by the person administering the
veterinary
medicinal product to animals
Flammable. Prepare and use the dilution of the product in a
well-ventilated
area.
Wear waterproof gloves, apron and face shield when handling the
product
and wash all protective clothing thoroughly after use, including the
inside of
gloves.
May cause sensitisation (allergy) by skin contact. Avoid any contact
of the
product with the skin or eyes. In case of skin contamination, wash
thoroughly with soap and water. In case of eye contamination, rinse
with
plenty of clean, running water immediately. If irritation persists,
seek
medical help.
Do not eat drink or smoke whilst using the product.
When treatment is completed, wash hands thoroughly before eating,
drinking or smoking.
Do not h